Correlation Between BioNTech and CVS Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNTech and CVS Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and CVS Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and CVS Health Corp, you can compare the effects of market volatilities on BioNTech and CVS Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of CVS Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and CVS Health.

Diversification Opportunities for BioNTech and CVS Health

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between BioNTech and CVS is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and CVS Health Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CVS Health Corp and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with CVS Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CVS Health Corp has no effect on the direction of BioNTech i.e., BioNTech and CVS Health go up and down completely randomly.

Pair Corralation between BioNTech and CVS Health

Assuming the 90 days trading horizon BioNTech is expected to generate 3.87 times less return on investment than CVS Health. In addition to that, BioNTech is 1.03 times more volatile than CVS Health Corp. It trades about 0.02 of its total potential returns per unit of risk. CVS Health Corp is currently generating about 0.07 per unit of volatility. If you would invest  5,737  in CVS Health Corp on August 27, 2024 and sell it today you would earn a total of  264.00  from holding CVS Health Corp or generate 4.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

BioNTech SE  vs.  CVS Health Corp

 Performance 
       Timeline  
BioNTech SE 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady essential indicators, BioNTech disclosed solid returns over the last few months and may actually be approaching a breakup point.
CVS Health Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in CVS Health Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, CVS Health is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

BioNTech and CVS Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNTech and CVS Health

The main advantage of trading using opposite BioNTech and CVS Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, CVS Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Health will offset losses from the drop in CVS Health's long position.
The idea behind BioNTech SE and CVS Health Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges